These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 20638606
1. Macrolide-resistant Streptococcus pyogenes from Chinese pediatric patients in association with Tn916 transposons family over a 16-year period. Feng L, Lin H, Ma Y, Yang Y, Zheng Y, Fu Z, Yu S, Yao K, Shen X. Diagn Microbiol Infect Dis; 2010 Aug; 67(4):369-75. PubMed ID: 20638606 [Abstract] [Full Text] [Related]
2. The trend of macrolide resistance and emm types of group A streptococci from children at a medical center in southern Taiwan. Chuang PK, Wang SM, Lin HC, Cho YH, Ma YJ, Ho TS, Shen CF, Liu CC. J Microbiol Immunol Infect; 2015 Apr; 48(2):160-7. PubMed ID: 24094501 [Abstract] [Full Text] [Related]
3. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types. Michos AG, Bakoula CG, Braoudaki M, Koutouzi FI, Roma ES, Pangalis A, Nikolopoulou G, Kirikou E, Syriopoulou VP. Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219 [Abstract] [Full Text] [Related]
5. Epidemiology and molecular characterization of macrolide-resistant Streptococcus pyogenes in Taiwan. Huang CY, Lai JF, Huang IW, Chen PC, Wang HY, Shiau YR, Cheng YW, Hsieh LY, Chang SC, Lauderdale TL. J Clin Microbiol; 2014 Feb; 52(2):508-16. PubMed ID: 24478481 [Abstract] [Full Text] [Related]
6. Antibiotic resistance and molecular analysis of Streptococcus pyogenes isolated from healthy schoolchildren in China. Chang H, Shen X, Fu Z, Liu L, Shen Y, Liu X, Yu S, Yao K, Zhao C, Yang Y. Scand J Infect Dis; 2010 Feb; 42(2):84-9. PubMed ID: 19883153 [Abstract] [Full Text] [Related]
8. Molecular epidemiology, antimicrobial susceptibilities and resistance mechanisms of Streptococcus pyogenes isolates resistant to erythromycin and tetracycline in Spain (1994-2006). Rubio-López V, Valdezate S, Alvarez D, Villalón P, Medina MJ, Salcedo C, Sáez-Nieto JA. BMC Microbiol; 2012 Sep 21; 12():215. PubMed ID: 22998619 [Abstract] [Full Text] [Related]
9. Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China. Li H, Zhou L, Zhao Y, Ma L, Liu X, Hu J. BMC Infect Dis; 2020 Jul 13; 20(1):507. PubMed ID: 32660436 [Abstract] [Full Text] [Related]
10. Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13). Michos A, Koutouzi FI, Tsakris A, Chatzichristou P, Koutouzis EI, Daikos GL, Stathi A, Syriopoulou VP. J Antimicrob Chemother; 2016 Aug 13; 71(8):2113-7. PubMed ID: 27118782 [Abstract] [Full Text] [Related]
11. Evolution of macrolide resistance in Streptococcus pyogenes over 14 years in an area of central Italy. Olivieri R, Morandi M, Zanchi A, Tordini G, Pozzi G, De Luca A, Montagnani F. J Med Microbiol; 2015 Oct 13; 64(10):1186-1195. PubMed ID: 26224594 [Abstract] [Full Text] [Related]
12. Molecular emm typing of Bulgarian macrolide-resistant Streptococcus pyogenes isolates. Muhtarova A, Mihova K, Markovska R, Mitov I, Kaneva R, Gergova R. Acta Microbiol Immunol Hung; 2019 Dec 13; 67(1):14-17. PubMed ID: 31833385 [Abstract] [Full Text] [Related]
13. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008). Ardanuy C, Domenech A, Rolo D, Calatayud L, Tubau F, Ayats J, Martín R, Liñares J. J Antimicrob Chemother; 2010 Apr 13; 65(4):634-43. PubMed ID: 20118164 [Abstract] [Full Text] [Related]
14. Description of macrolide-resistant and potential virulent clones of Streptococcus pyogenes causing asymptomatic colonization during 2000-2006 in the Lisbon area. Pires R, Rolo D, Morais A, Brito-Avô A, Johansson C, Henriques-Normark B, Gonçalo-Marques J, Santos-Sanches I. Eur J Clin Microbiol Infect Dis; 2012 May 13; 31(5):849-57. PubMed ID: 22012657 [Abstract] [Full Text] [Related]
15. Molecular epidemiology, antimicrobial susceptibility, and characterization of macrolide-resistant Streptococcus pyogenes in Japan. Tanaka Y, Gotoh K, Teramachi M, Ishimoto K, Tsumura N, Shindou S, Yamashita Y. J Infect Chemother; 2016 Nov 13; 22(11):727-732. PubMed ID: 27645122 [Abstract] [Full Text] [Related]
16. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL, Doern CD, Reid SD, Doern GV. Clin Infect Dis; 2005 Sep 01; 41(5):599-608. PubMed ID: 16080080 [Abstract] [Full Text] [Related]
19. Associations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 2010-2012. Wajima T, Morozumi M, Chiba N, Shouji M, Iwata S, Sakata H, Ubukata K. Int J Antimicrob Agents; 2013 Nov 01; 42(5):447-9. PubMed ID: 23988719 [Abstract] [Full Text] [Related]
20. Changes in epidemiologic characteristics and antimicrobial resistance of Streptococcus pyogenes isolated over 10 years from Japanese children with pharyngotonsillitis. Ubukata K, Wajima T, Morozumi M, Sakuma M, Tajima T, Matsubara K, Itahashi K, Iwata S. J Med Microbiol; 2020 Mar 01; 69(3):443-450. PubMed ID: 32011228 [Abstract] [Full Text] [Related] Page: [Next] [New Search]